Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plasmodium berghei | 14 | 2024 | 34 | 3.840 |
Why?
|
| Antimalarials | 13 | 2024 | 64 | 2.890 |
Why?
|
| Plasmodium falciparum | 12 | 2024 | 144 | 2.200 |
Why?
|
| Malaria | 9 | 2024 | 90 | 1.910 |
Why?
|
| Drug Synergism | 2 | 2024 | 195 | 1.600 |
Why?
|
| Glutathione | 4 | 2016 | 171 | 1.330 |
Why?
|
| Glutamate-Cysteine Ligase | 5 | 2016 | 17 | 1.170 |
Why?
|
| Protozoan Proteins | 9 | 2015 | 191 | 0.980 |
Why?
|
| Hydrazones | 1 | 2024 | 11 | 0.850 |
Why?
|
| Drug Combinations | 2 | 2024 | 104 | 0.850 |
Why?
|
| Glutathione Reductase | 2 | 2016 | 19 | 0.810 |
Why?
|
| Chloroquine | 3 | 2015 | 19 | 0.790 |
Why?
|
| Drug Resistance, Multiple | 5 | 2009 | 28 | 0.680 |
Why?
|
| Artemisinins | 2 | 2015 | 19 | 0.670 |
Why?
|
| Malaria, Falciparum | 6 | 2024 | 90 | 0.660 |
Why?
|
| ATP-Binding Cassette Transporters | 4 | 2009 | 82 | 0.630 |
Why?
|
| Plasmodium yoelii | 3 | 2004 | 10 | 0.570 |
Why?
|
| Tropical Medicine | 1 | 2016 | 10 | 0.490 |
Why?
|
| Erythrocytes | 4 | 2017 | 126 | 0.480 |
Why?
|
| Drug Resistance | 2 | 2015 | 96 | 0.440 |
Why?
|
| Schools, Medical | 1 | 2016 | 208 | 0.420 |
Why?
|
| Oocysts | 2 | 2010 | 5 | 0.400 |
Why?
|
| Mice | 16 | 2024 | 6644 | 0.400 |
Why?
|
| Animals | 23 | 2024 | 16992 | 0.360 |
Why?
|
| Public Health | 1 | 2016 | 424 | 0.360 |
Why?
|
| Parasitemia | 1 | 2011 | 13 | 0.350 |
Why?
|
| Staining and Labeling | 1 | 2011 | 107 | 0.340 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 182 | 0.320 |
Why?
|
| Flow Cytometry | 1 | 2011 | 411 | 0.320 |
Why?
|
| Polymerase Chain Reaction | 5 | 2017 | 455 | 0.300 |
Why?
|
| Computational Biology | 1 | 2009 | 327 | 0.240 |
Why?
|
| Plasmodium vivax | 2 | 2024 | 8 | 0.240 |
Why?
|
| Molecular Sequence Data | 7 | 2011 | 1542 | 0.220 |
Why?
|
| Plasmodium cynomolgi | 1 | 2024 | 4 | 0.220 |
Why?
|
| Genes, MDR | 1 | 2004 | 2 | 0.210 |
Why?
|
| Hep G2 Cells | 1 | 2024 | 63 | 0.210 |
Why?
|
| Drug Therapy, Combination | 1 | 2024 | 234 | 0.200 |
Why?
|
| Sporozoites | 2 | 2015 | 6 | 0.190 |
Why?
|
| Amino Acid Sequence | 5 | 2009 | 1180 | 0.180 |
Why?
|
| Female | 12 | 2024 | 24698 | 0.170 |
Why?
|
| Chromosome Mapping | 3 | 2009 | 199 | 0.160 |
Why?
|
| Fasciola hepatica | 3 | 1986 | 34 | 0.150 |
Why?
|
| Blotting, Southern | 3 | 2009 | 68 | 0.150 |
Why?
|
| Travel | 1 | 1999 | 36 | 0.150 |
Why?
|
| Mefloquine | 1 | 1999 | 4 | 0.150 |
Why?
|
| Indoles | 2 | 2011 | 187 | 0.150 |
Why?
|
| Genes, Protozoan | 1 | 1999 | 18 | 0.150 |
Why?
|
| Chromosomes | 1 | 1999 | 43 | 0.140 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 458 | 0.140 |
Why?
|
| Structure-Activity Relationship | 3 | 2014 | 506 | 0.130 |
Why?
|
| Humans | 9 | 2024 | 43102 | 0.130 |
Why?
|
| DNA, Protozoan | 3 | 2002 | 26 | 0.130 |
Why?
|
| Open Reading Frames | 2 | 2009 | 79 | 0.120 |
Why?
|
| RNA, Protozoan | 2 | 2009 | 13 | 0.120 |
Why?
|
| Life Cycle Stages | 1 | 2016 | 29 | 0.120 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 53 | 0.120 |
Why?
|
| History, 20th Century | 1 | 2016 | 121 | 0.120 |
Why?
|
| Thioredoxins | 1 | 2016 | 41 | 0.120 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 191 | 0.110 |
Why?
|
| Blood | 3 | 2015 | 37 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 97 | 0.110 |
Why?
|
| Sequence Alignment | 2 | 2009 | 272 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 2016 | 383 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2017 | 329 | 0.100 |
Why?
|
| DNA Damage | 1 | 2016 | 356 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 2 | 2017 | 256 | 0.100 |
Why?
|
| Gene Expression | 2 | 2009 | 701 | 0.100 |
Why?
|
| Schistosoma mansoni | 2 | 1983 | 21 | 0.100 |
Why?
|
| Antigens | 2 | 1983 | 59 | 0.090 |
Why?
|
| Liver | 1 | 2015 | 511 | 0.090 |
Why?
|
| Antioxidants | 1 | 2016 | 443 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 652 | 0.090 |
Why?
|
| Thiazepines | 1 | 2011 | 4 | 0.090 |
Why?
|
| Electron Transport Complex III | 1 | 2011 | 13 | 0.090 |
Why?
|
| Bisbenzimidazole | 1 | 2011 | 2 | 0.090 |
Why?
|
| Propidium | 1 | 2011 | 20 | 0.090 |
Why?
|
| Rhodamines | 1 | 2011 | 22 | 0.090 |
Why?
|
| Ribonucleases | 1 | 2011 | 32 | 0.090 |
Why?
|
| Puerto Rico | 1 | 2016 | 1413 | 0.090 |
Why?
|
| Gene Dosage | 2 | 2004 | 75 | 0.090 |
Why?
|
| Limit of Detection | 1 | 2011 | 94 | 0.090 |
Why?
|
| Fluorescence | 1 | 2011 | 118 | 0.090 |
Why?
|
| Silanes | 1 | 2010 | 5 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 209 | 0.080 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 8 | 0.080 |
Why?
|
| Glutathione Disulfide | 1 | 2010 | 8 | 0.080 |
Why?
|
| Eosine I Bluish | 1 | 2010 | 3 | 0.080 |
Why?
|
| Methylene Blue | 1 | 2010 | 7 | 0.080 |
Why?
|
| Fluoresceins | 1 | 2010 | 29 | 0.080 |
Why?
|
| Amines | 1 | 2010 | 41 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2016 | 1003 | 0.080 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 2000 | 29 | 0.080 |
Why?
|
| Base Sequence | 3 | 2002 | 983 | 0.080 |
Why?
|
| Hepatocytes | 2 | 2015 | 80 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 665 | 0.070 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2009 | 27 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2009 | 39 | 0.070 |
Why?
|
| Anopheles | 1 | 2009 | 21 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 113 | 0.070 |
Why?
|
| Drug Design | 1 | 2010 | 186 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 160 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2004 | 1271 | 0.070 |
Why?
|
| Male | 3 | 2024 | 23409 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 575 | 0.070 |
Why?
|
| Fascioliasis | 1 | 1986 | 16 | 0.060 |
Why?
|
| Antigens, Helminth | 1 | 1986 | 34 | 0.060 |
Why?
|
| Schistosomiasis | 2 | 1983 | 19 | 0.060 |
Why?
|
| Mitochondria | 1 | 2009 | 523 | 0.060 |
Why?
|
| Gene Amplification | 2 | 1999 | 23 | 0.060 |
Why?
|
| Paragonimus | 1 | 1983 | 1 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1455 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2004 | 883 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 166 | 0.040 |
Why?
|
| Primaquine | 1 | 2000 | 1 | 0.040 |
Why?
|
| Sulfadoxine | 1 | 2000 | 6 | 0.040 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2000 | 13 | 0.040 |
Why?
|
| Pyrimethamine | 1 | 2000 | 10 | 0.040 |
Why?
|
| Colombia | 1 | 2000 | 31 | 0.040 |
Why?
|
| Sentinel Surveillance | 1 | 2000 | 25 | 0.040 |
Why?
|
| DNA Primers | 1 | 2000 | 294 | 0.040 |
Why?
|
| Karyotyping | 1 | 1999 | 45 | 0.040 |
Why?
|
| Mutation | 2 | 2015 | 1177 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1986 | 458 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 314 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 611 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 2017 | 19 | 0.030 |
Why?
|
| Urban Population | 1 | 2000 | 374 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2017 | 210 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 100 | 0.030 |
Why?
|
| Immunodiffusion | 2 | 1986 | 4 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2015 | 79 | 0.030 |
Why?
|
| Prevalence | 1 | 2000 | 1612 | 0.030 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2014 | 2 | 0.030 |
Why?
|
| Lactams, Macrocyclic | 1 | 2014 | 8 | 0.030 |
Why?
|
| Rabbits | 2 | 1986 | 278 | 0.030 |
Why?
|
| Solubility | 1 | 2014 | 139 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 1621 | 0.020 |
Why?
|
| Rats | 2 | 2011 | 3735 | 0.020 |
Why?
|
| Mice, Inbred CBA | 2 | 1983 | 42 | 0.020 |
Why?
|
| Atovaquone | 1 | 2011 | 1 | 0.020 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2011 | 15 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2000 | 3156 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 423 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 51 | 0.020 |
Why?
|
| Dogs | 1 | 2011 | 204 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 1869 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 158 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 127 | 0.020 |
Why?
|
| Binding Sites | 1 | 2011 | 671 | 0.020 |
Why?
|
| Imidazoles | 1 | 2010 | 142 | 0.020 |
Why?
|
| Invertebrate Hormones | 1 | 1989 | 1 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2010 | 570 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 1081 | 0.020 |
Why?
|
| Chemical Fractionation | 1 | 1986 | 14 | 0.020 |
Why?
|
| Octoxynol | 1 | 1986 | 19 | 0.020 |
Why?
|
| Detergents | 1 | 1986 | 25 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1410 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1986 | 52 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1986 | 108 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 1596 | 0.010 |
Why?
|
| Middle Aged | 1 | 1999 | 12222 | 0.010 |
Why?
|
| Immune Sera | 1 | 1983 | 56 | 0.010 |
Why?
|
| Immunization | 1 | 1983 | 94 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1982 | 87 | 0.010 |
Why?
|
| Immunity | 1 | 1982 | 61 | 0.010 |
Why?
|
| Antibodies | 1 | 1982 | 144 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1982 | 259 | 0.010 |
Why?
|
| Vaccination | 1 | 1982 | 355 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1989 | 88 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 70 | 0.000 |
Why?
|